Cargando…

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

PURPOSE: To evaluate efficacy and toxicity clinical in the intensified treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN) with the combination of chemotherapy, the EGFR antibody cetuximab, and intensity-modulated radiation therapy (IMRT) in a concomitant boost concept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensen, Alexandra D, Krauss, Jürgen, Potthoff, Karin, Simon, Christian, Nikoghosyan, Anna V, Lossner, Karen, Debus, Jürgen, Münter, Marc W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342898/ https://www.ncbi.nlm.nih.gov/pubmed/22472064 http://dx.doi.org/10.1186/1748-717X-7-57

Ejemplares similares

IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial
por: Jensen, Alexandra D, et al.
Publicado: (2012)

Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12)
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC
por: Jensen, Alexandra D, et al.
Publicado: (2010)

Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol
por: Habl, Gregor, et al.
Publicado: (2010)

Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx
por: Hauswald, H., et al.
Publicado: (2018)

Carbon ion therapy for ameloblastic carcinoma
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Carbon ion therapy for advanced sinonasal malignancies: feasibility and acute toxicity
por: Jensen, Alexandra D, et al.
Publicado: (2011)

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab
por: Jensen, Alexandra D, et al.
Publicado: (2010)

Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study
por: Nikoghosyan, Anna V, et al.
Publicado: (2010)

Raster-scanned carbon ion therapy for malignant salivary gland tumors: acute toxicity and initial treatment response
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study
por: Nikoghosyan, Anna V, et al.
Publicado: (2010)

Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment
por: Münter, MW, et al.
Publicado: (2006)

Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Intensity modulated radiotherapy (IMRT) in the treatment of children and Adolescents - a single institution's experience and a review of the literature
por: Sterzing, Florian, et al.
Publicado: (2009)

Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010)

Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes
por: Combs, Stephanie E, et al.
Publicado: (2006)

Simultaneous integrated boost for adjuvant treatment of breast cancer- intensity modulated vs. conventional radiotherapy: The IMRT-MC2 trial
por: Askoxylakis, Vasileios, et al.
Publicado: (2011)

Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT
por: Jensen, Alexandra D, et al.
Publicado: (2012)

Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck
por: Jensen, A D, et al.
Publicado: (2019)

Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis
por: Roeder, Falk, et al.
Publicado: (2014)

Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience
por: Jensen, Alexandra D, et al.
Publicado: (2010)

Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands
por: Schmid, Maximilian P., et al.
Publicado: (2021)

Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, prospective, open-label, randomized, two-arm, phase III study
por: König, Laila, et al.
Publicado: (2021)

Intensity-modulated radiotherapy with integrated-boost in patients with bone metastasis of the spine: study protocol for a randomized controlled trial
por: Sprave, Tanja, et al.
Publicado: (2018)

Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner
por: Werthmöller, N, et al.
Publicado: (2015)

Acute toxicity of normofractionated intensity modulated radiotherapy with simultaneous integrated boost compared to three-dimensional conformal radiotherapy with sequential boost in the adjuvant treatment of breast cancer
por: Krug, David, et al.
Publicado: (2020)

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity
por: Lang, Kristin, et al.
Publicado: (2018)

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
por: Adeberg, Sebastian, et al.
Publicado: (2019)

Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) – Pilot trial of a phase I/II study: study protocol
por: Rochet, Nathalie, et al.
Publicado: (2007)

Intensity-Modulated Radiotherapy with Concomitant Boost After Breast Conserving Surgery: A Phase I–II Trial
por: Macchia, Gabriella, et al.
Publicado: (2020)

COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
por: Roncati, Luca, et al.
Publicado: (2020)

Using biologically based objectives to optimize boost intensity‐modulated radiation therapy planning for brainstem tumors in dogs
por: Meier, Valeria, et al.
Publicado: (2019)

Subtle mutation, far-reaching effects
por: Apell, Hans-Jürgen
Publicado: (2017)

Resistance training concomitant to radiotherapy of spinal bone metastases – survival and prognostic factors of a randomized trial
por: Rief, Harald, et al.
Publicado: (2016)

Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients
por: Sterzing, Florian, et al.
Publicado: (2015)

Intensity modulated radiotherapy (IMRT) in benign giant cell tumors -- a single institution case series and a short review of the literature
por: Roeder, Falk, et al.
Publicado: (2010)

Intensity-modulated radiotherapy for the management of primary and recurrent chordomas: a retrospective long-term follow-up study
por: Wolf, Robert J., et al.
Publicado: (2023)

Helical intensity-modulated Radiotherapy of the Pelvic Lymph Nodes with Integrated Boost to the Prostate Bed - Initial Results of the PLATIN 3 Trial
por: Katayama, Sonja, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lh9r8oq7snjdj5lnim2k85lbcq